Longview Acquisition Corp. II
Liquidated 2022-12-14- CIK 1832300
- LGV
- IPO 2021-03-22
- $693M trust
- 79 filings
- IPO Size
- $690M
- raised at the IPO
- Trust
- $693M
- as of 2022-09-30
- Current Status
- Failed
- from its latest filing
- IPO Year
- 2021
- year it listed
Filings, by quarter
79 filings over 9 quarters; violet bars carry a milestone
- 21 Q1: 22 filings
- 21 Q2: 4 filings
- 21 Q3: 19 filings
- 21 Q4: 11 filings
- 22 Q1: 5 filings
- 22 Q2: 1 filing
- 22 Q3: 2 filings
- 22 Q4: 13 filings
- 23 Q1: 2 filings
S-1 filed
IPO
Liquidated
- S-1 filed 21 Q1
- IPO 21 Q1
- Liquidated 22 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Longview Acquisition Corp. II is a blank-check company seeking an initial business combination with an established business, with a particular emphasis on healthcare and broader sector interests.
Investment Focus
Healthcare, Industrial, Consumer, Media, Technology, IT Services
Key Information
As the filings state it
- IPO Date
- 2021-03-22
- Total Redemptions
- $613M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Failed Date
- 2022-12-14
- SPAC Ticker
- LGV
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Led by Chairman Larry Robbins, CEO John Rodin and CFO Mark Horowitz, supported by director nominees Westley Moore, Shalinee Sharma and Brian Zied. Team backgrounds include Glenview investment experience, public-company engagement, operating, investment banking, financial, and nonprofit leadership.